| Display title | Chemistry:Mebanazine |
| Default sort key | Mebanazine |
| Page length (in bytes) | 2,950 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 537698 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Corlink |
| Date of page creation | 03:34, 9 March 2024 |
| Latest editor | imported>Corlink |
| Date of latest edit | 03:34, 9 March 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Mebanazine (trade name Actomol) is a monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class that was previously used as an antidepressant in the 1960s, but has since been withdrawn due to hepatotoxicity.
Mebanazine in animals is claimed to be a more potent MAOI than pheniprazine with a greater... |
